using gwas and sequence data to identify and validate drug targets
Published 6 years ago • 517 plays • Length 36:57Download video MP4
Download video MP3
Similar videos
-
40:49
rare variants and drug target discovery
-
50:28
the future of gwas in drug discovery and biobank design
-
52:09
applications of human genetics in drug discovery to present and future indications
-
48:26
large-scale cognitive gwas & tissue-specific expression & nootropic drug targets
-
17:15
leveraging human genetics data to guide drug target validation - mesut erzurumluoglu (31/10/21)
-
4:22
genomic wide association study
-
22:22
genome‐wide target‐id and validation techniques for novel drug discovery
-
36:16
cadr conference 2024 dr becky sims genes and disease
-
0:59
how do pharmaceutical companies use genomic data for drug discovery?
-
52:42
genetics, genomics, and drug discovery - lon cardon
-
49:31
genomic advances in drug discovery & development - lon cardon, ph.d.
-
59:45
[william reay] advancing the use of gwas for drug repurposing and precision treatment
-
2:23
deep molecular profiling to identify new genetic variants and drug targets in alzheimer’s disease
-
39:24
druggability and the druggable genome
-
3:38
discovery and validation of novel drug targets involved in neuroinflammation
-
29:06
discovering variants conferring risk for common diseases - michael boehnke
-
16:48
maze therapeutics aws: a human genetics platform for drug discovery and development
-
33:51
jeffrey barett’s keynote at discovery on target 2016
-
19:03
ac23 - genome-wide association study (gwas) updates